Skip NavigationSkip to Content

Enzymes Involved in the Bioactivation of 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone in Patas Monkey Lung and Liver Microsomes

  1. Author:
    Smith, T. J.
    Liao, A. M.
    Liu, Y.
    Jones, A. B.
    Anderson, L. M.
    Yang, C. S.
  2. Author Address

    Smith TJ RUTGERS STATE UNIV COLL PHARM CANC RES LAB PISCATAWAY, NJ 08855 USA NCI FREDERICK CANC RES & DEV CTR COMPARAT CARCINOGENESIS LAB FREDERICK, MD 21702 USA
    1. Year: 1997
  1. Journal: Carcinogenesis
    1. 18
    2. 8
    3. Pages: 1577-1584
  2. Type of Article: Article
  1. Abstract:

    4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) is a potent tobacco-specific carcinogen in animals, Our previous studies indicated that there are differences between rodents and humans for the enzymes involved in the activation of NNK. To determine if the patas monkey is a better animal model for the activation of NNK in humans, we investigated the metabolism of NNK in patas monkey Lung and liver microsomes and characterized the enzymes involved in the activation, In lung microsomes, the formation of 4-oxo-1-(3-pyridyl)-1-butanone (keto aldehyde), 4-(methylnitrosamino)-1-(3-pyridyl-N-oxide)-1-butanone (NNK-N-oxide), 4-hydroxy-1-(3-pyridyl)-1-butanone (keto alcohol), and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) was observed, displaying apparent K-m values of 10.3, 5.4, 4.9, and 902 mu M, respectively, NNK metabolism in liver microsomes resulted in the formation of keto aldehyde, keto alcohol, and NNAL, displaying apparent K-m values of 8.1, 8.2, and 474 mu M, respectively, The low K-m values for NNK oxidation in the patas monkey lung and Liver microsomes are different from those in human lung and liver microsomes showing K-m values of 400-653 mu M, although loss of low K-m forms from human tissue as a result of disease, surgery or anesthesia cannot be ruled out, Carbon monoxide (90%) significantly inhibited NNK metabolism in the patas monkey lung and liver microsomes by 38-66% and 82-91%, respectively, Nordihydroguaiaretic acid (a lipoxygenase inhibitor) and aspirin (a cyclooxygenase inhibitor) decreased the rate of formation of keto aldehyde and keto alcohol by 10-20% in the monkey lung microsomes, alpha-Napthoflavone and coumarin markedly decreased the oxidation of NNK in monkey lung and liver microsomes, suggesting the involvement of p450s 1A and 2A6. An antibody against human P450 2A6 decreased the oxidation of NNK hy 12-16% and 22-24% in the patas monkey lung and liver microsomes, respectively, These results are comparable to that obtained with human lung and liver microsomes. Coumarin hydroxylation was observed in the patas monkey lung and liver microsomes at a rate of 16 and 4000 pmol/min/mg protein, respectively, which was 5-fold higher than human lung and liver microsomes, respectively, Immunoblot analysis demonstrated that the P450 2A level in the individual patas monkey liver microsomal sample was 6-fold greater than in an individual human liver microsomal sample. Phenethyl isothiocyanate, an inhibitor of NNK activation in rodents and humans, decreased NNK oxidation in the monkey lung and liver microsomes displaying inhibitor concentration resulting in 50% inhibition of the activity (IC50) values of 0.28-0.8 mu M and 4.2-6.8 mu M, respectively, The results demonstrate the similarities and differences between species in the metabolic activation of NNK, The patas monkey microsomes appear to more closely resemble human microsomes than mouse or rat enzymes and may better reflect the activation of NNK in humans. [References: 36]

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel